PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.07%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-29.08%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-7.18%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
4.38%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
4.94%
R&D change of 4.94% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
128.01%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-2.24%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
18.83%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
3.66%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
161.11%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
-29.90%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-21.13%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-29.90%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-21.17%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
18.10%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-26.00%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-16.79%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-26.03%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-25.99%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-16.77%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-25.00%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-28.13%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.19%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.23%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.